Teva acquires Mexican company Rimsa for $2.3b
2 October 2015 | By Victoria White
Through the Rimsa acquisition, Teva will become a leading pharmaceutical company in the second largest market in Latin America...
List view / Grid view
2 October 2015 | By Victoria White
Through the Rimsa acquisition, Teva will become a leading pharmaceutical company in the second largest market in Latin America...
2 October 2015 | By Victoria White
Sandoz is seeking approval for all indications included in the label of etanercept which is used to treat a range of autoimmune diseases including rheumatoid arthritis and psoriasis...
2 October 2015 | By Victoria White
Moxatag is a penicillin-class antibacterial indicated for the treatment of tonsillitis and pharyngitis secondary to streptococcus pyogenes...
2 October 2015 | By Victoria White
Raxone is also the first approved treatment for any mitochondrial disease, a therapeutic area which is in the focus of Santhera...
2 October 2015 | By Victoria White
Merck and DNAtrix will evaluate the efficacy and safety of DNX-2401 in combination with Keytruda in a Phase 2 study...
1 October 2015 | By Victoria White
The acquisition of Kythera adds Kybella, an injection for improvement in the appearance of moderate to severe submental fullness, to Allergan’s portfolio...
1 October 2015 | By Victoria White
Genzyme has elected to opt into the programme for development and potential future commercialisation of ALN-AT3 in territories outside of North America and Western Europe...
1 October 2015 | By Victoria White
The announcement marks the first and only FDA approval of a Regimen of two immuno-oncology agents in cancer...
1 October 2015 | By Victoria White
Secukinumab is the first interleukin-17A inhibitor to demonstrate efficacy in a Phase III study in patients with active psoriatic arthritis...
1 October 2015 | By Victoria White
Brodalumab is the only investigational treatment in development that binds to the interleukin-17 (IL-17) receptor and inhibits inflammatory signalling...
1 October 2015 | By Victoria White
The company has opened a Scientific Office in Saudi Arabia and has appointed Dr Fahad Al Showaier as Scientific Office Manager...
30 September 2015 | By Victoria White
If approved, Translarna would be the first oral protein restoration treatment that targets the underlying cause of nonsense mutation cystic fibrosis...
30 September 2015 | By Victoria White
Pregnant women who received the anti-HIV drug in their third trimester gave birth to babies whose bone mineral content was 12% lower than that of infants who were not exposed to the drug...
30 September 2015 | By Coulter Partners
Global Life Sciences search specialist, Coulter Partners is pleased to announce the appointments of Anne-Monika Dürk as Executive Vice President, Thomas Pilz as Research Associate and Ronja Lindenberg as Executive Assistant in their new Frankfurt offices....
CPhI Worldwide, organised by UBM EMEA, today announced the findings of Part II of its 2015 annual report, entitled, ‘Quality, metrics and continuous processing’, ahead of CPhI Worldwide 2015 in Madrid.